CLINICAL STUDIES

Clostridium difficile (C-Diff)

“A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER”

Study Phase:

Phase 3

Criteria:

  • Male or Female 50 years or older
  • At least 1 hospitalization n in the previous 12 months (2 Nights) OR or At least 2 emergency room visits in the previous 12 months
Register